Structure basis for molecular recognition of folic acid by folate receptor

STRUCTURAL BASIS FOR MOLECULAR RECOGNITION OF FOLIC ACID BY FOLATE RECEPTORS CHEN CHEN B.Sc (Hons.), Nanyang Technological University A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY NUS GRADUATE SCHOOL FOR INTEGRATIVE SCIENCES AND ENGINEERING NATIONAL UNIVERSITY OF SINGAPORE 2014 DECLARATION DECLARATION I hereby declare that this thesis is my original work and it has been written by me in its entirety I have duly acknowledged all the sources of information which have been used in the thesis This thesis has also not been submitted for any degree in any university previously 陈晨 Chen Chen i ACKNOWLEDGEMENT Acknowledgement I would like to express my heartfelt gratitude to all of them who have helped me during the course of my Ph.D First and foremost, I wish to thank my main supervisor, Professor Yong Eu-Leong for providing me the opportunity to start this wonderful research experience I appreciate his scientific advice in conceptualizing the project and valuable training for my presentation skills Besides, I am deeply grateful for his continuous support and guidance during my 2-year overseas attachment I would also like to acknowledge the Department of Obstetrics and Gynaecology for supporting my studies in NUS I would like to thank my TAC members Dr Song Hai-wei and Dr Li Jun for their incessant monitoring of my research progress and keeping me on track I appreciate their precious advice in my Ph.D qualifying examination and thesis I would also like to thank Dr Inthrani Raja Indran for taking the time to comment on this thesis I am very grateful for Dr Eric Xu and Dr Karsten Melcher, who supervised me in Van Andel Institute of Research, US Their close guidance not only equipped me with technical skills in protein crystallography, but also inspired my enthusiasm in research I wish to thank Dr Jiyuan Ke, who worked closely with me in my Ph.D project I have learnt a lot from his scientific advice and professional experience I am thankful for all the members in Eric's lab, who helped me immensely in my research as well as daily life, and made my overseas attachment enjoyable and memorable I would like to acknowledge and thank NGS for providing me the 4-year PhD scholarship and the opportunity to participate the "2+2" collaborative program ii ACKOWLEDGEMENT In addition, I would like to thank Van Andel Institute of Research for hosting my overseas attachment Last but not least, I would like to express my deepest gratitude to my family and friends Without their unfailing encouragement and support, I would not finish this challenging journey iii TABLE OF CONTENT TABLE OF CONTENTS Declaration .i Acknowledgements ii Table of contents iv Summary .vii List of tables ix List of figures x List of abbreviations xii Chapter 1: Literature review 1.1 Folate 1.1.1 Introduction of folate 1.1.2 Folate metabolism .4 1.1.3 Folate transport system 1.2 Folate deficiency 1.2.1 Neural tube defects 1.2.2 Vascular diseases .12 1.2.3 Cancer 12 1.3 Antifolate 14 1.4 Folate receptors 19 1.4.1 Expression, localization and function of folate receptors 19 1.4.2 Physiological roles of folate receptors .20 1.4.3 Implication of folate receptors in human diseases 21 1.5 Current drugs targeting folate receptors 24 1.5.1 FRα-antibody .24 1.5.2 Novel antifolates .25 1.5.3 Folate conjugates .25 1.6 Aims and significance of the study 29 iv TABLE OF CONTENT Chapter 2: Materials and methods .31 2.1 Plasmid construction 32 2.2 Cell culture .33 2.3 Stable cell selection 34 2.4 Protein expression and purification 35 2.4.1 Small scale purification of recombinant proteins 35 2.4.2 Large scale purification of recombinant proteins 36 2.5 Protein crystallization and data collection 38 2.6 Structure determination 40 2.7 Mutagenesis 41 2.8 Western blot .41 2.9 Radioligand binding assay .42 Chapter 3: Results 43 3.1 Bacterial expression of FRs 44 3.1.1 Screening of bacterial expression tags for FRα 44 3.1.2 Screening of FRs from different species 45 3.1.3 Purification and in vitro refolding of MBP-FRα fusion protein 48 3.2 Mammalian expression of FRs 50 3.2.1 Transient expression of MBP-FRα-MBP fusion protein 50 3.2.2 Stable clone expression of FRα-Fc fusion protein 52 3.2.3 Crystallization of wild type FRα protein 54 3.3 Deglycosylation of FRs 56 3.3.1 Point mutation of glycosylation sites 56 3.3.2 Endo F3 treatment of FRα 58 3.3.3 Combined treatment of kifunensine and Endo H 60 3.4 Structure determination 63 3.4.1 Molecular replacement 63 3.4.2 Isomorphous replacement 64 v TABLE OF CONTENT 3.4.3 Single anomalous diffraction 65 3.5 Overall structure of FRα and ligand binding pocket 67 3.6 Mutagenesis and ligand binding assay .72 Chapter 4: Discussion 76 4.1 Structure comparison between FRα and chicken RfBP 77 4.2 Structure of FRβ and pH-dependent ligand release mechanism 80 4.3 Structure-based rational drug design 86 4.3.1 DHFR structure and drug discovery 88 4.3.2 GARFT structure and AG2034 discovery 92 4.3.3 TS structure and Nolatrexed discovery .96 4.4 Development of Novel FR-targeted antifolate .101 4.4.1 Current efforts in developing FR-targeted antifolates .102 4.4.2 Structural insights of antifolate binding by FRs 105 4.5 Conclusions and perspectives 109 References 110 Publications 122 vi SUMMARY SUMMARY Folates also known as vitamin B9 are essential substrates for de novo nucleic acid synthesis and for many biological methylation processes As a result, folate deficiency is associated with numerous diseases such as fetal neural tube defects, cardiovascular diseases, and cancers High affinity uptake of folates requires folate receptors (FRα, β, γ), which are cell surface glycoproteins mediating folate intake by endocytosis FRα is the most prevalent isoform of FRs, and its expression is restricted to apical surface of epithelial cells in choroid plexus, proximal kidney tubules and placenta In contrast to limited normal tissue distribution, FRα is overexpressed in a spectrum of tumors, such as ovarian cancer, endometrial cancer and breast cancer As such, FRα has become the molecular target for the development of many cancer therapeutics Despite intense research on the folate structureactivity relationship, the molecular basis for the high affinity recognition of folates by FRα remains elusive due to the technical difficulties in expression, purification, and crystallization of FRα for structural studies Here, we developed a mammalian expression system which yielded correctly folded cysteine-rich FRα in sufficient amount for crystallization By combining the treatments of glycosylation inhibitor and enzymatic deglycosylation, we obtained homogenous protein which produced crystals diffracting to 2.8Å We solved the crystal structure of FRα-folic acid complex which provided the molecular basis for the high affinity binding Folate receptor is a globular protein which consists of six helices, two pairs of β-sheets and many loop regions which are stabilized by eight disulfide bonds vii SUMMARY FRα has a deep binding pocket with one end open, which accommodates folic acid with its pteroate moiety buried inside and glutamate group sticking outside The overall structure assumes a hand-like structure The binding pocket is almost perpendicular to the plane formed by helix α1, α2 and α3, which is the palm of the hand Whereas the N-terminal loop, loops between α1-α2, β1-β2 and α3-α4 are the fingers which grab the folic acid in middle The crystal structure also revealed the detailed folic acid binding mechanism of FRα First, the overall shape and charge distribution of FRα ligand binding pocket is complementary to folic acid The basic pteroate head of folic acid is buried within the positively charged interior of the pocket, whilst the acidic tail of folic acid is stabilized by the negatively charged exterior Second, the parallel side chains of Y85 and W171 stacking the pterin ring in between, together with D81, which forms a pair of strong hydrogen bonds with N1 and N2 of pterin, anchor folic acid inside the binding pocket Third, there is an extensive network of hydrogen bonds and hydrophobic interactions lining the binding pocket To validate these structural observations, we examined the ligand-binding affinities of FRα mutants that have alanine mutations in the key folate-contacting residues Results indicate that the extensive interaction network makes FRα–folic acid binding remarkably resistant to single point mutations In summary, the FRα–folic acid complex structure illustrates how the receptor assumes a deep folate-binding pocket that is formed by conserved residues across all receptor subtypes and provides detailed insights into how folic acid interacts with its receptors Together, these observations lay a foundation for future FR-targeted anticancer drug development viii LIST OF TABLES LIST OF TABLES Table 1: SNPs in folate-metabolism genes associated with NTDs 11 Table 2: Summary of antifolates 18 Table 3: Sequence identity between FRs from different species 46 Table 4: Statistics of data collection for deglycosylated FRα 63 Table 5: X-ray diffraction data and refinement statistics .66 ix DISCUSSION here Thus, a bulkier ligand which utilizes more space in the binding cleft can be synthesized and analyzed for increasing affinity Armed with the structural knowledge of FRs and folate metabolic enzymes (DHFR, GARFT and TS), we are now at the frontline of the development of novel FR-targeted antifolates, which is specific to tumor overexpressing FRs and cytotoxic by inhibiting nucleotides synthesis Structural studies of RFC and PCFT will be the way forward to provide critical information on how the transport of drugs to normal tissue via these two transporters can be minimized to eliminate toxicity 108 DISCUSSION 4.5 Conclusions and perspectives Folates are one-carbon donors that are required for the synthesis of nucleic acids Rapidly dividing cells, such as cancer cells, are therefore much more dependent on folates than quiescent body cells FRs are cell surface glycoproteins that mediate high affinity folate uptake through endocytosis FRs are significantly expressed only in few cells, in particular cells important for embryonic development (e.g placenta) and folate reabsorption (kidney), to allow selective folate uptake under folate-limiting conditions A large proportion of tumors therefore hijack FR and express it at very high levels to meet their folate demand High level expression of folate receptor is so cancerspecific that it is hotly pursued as an anticancer drug target In this study, we have overcome numerous technical barriers in the purification and crystallization of cysteine-rich glycoproteins and successfully solved the long awaited crystal structure of FRα bound to folic acid This structure provided a detailed map of the extensive interaction network between folic acid and FRs, and rationalizes previous structure-activity relationship studies of several folate derivatives, including antifolates and folate conjugates The information uncovered in this study paves the way for future structurebased rational drug design of more specific FR-targeted therapeutics 109 REFERENCES REFERENCES 10 11 12 13 14 15 Wills, L., Treatment of "Pernicious Anaemia of Pregnancy" and "Tropical Anaemia" Br Med J, 1931 1(3676): p 1059-64 Angier, R.B., J.H Boothe, and et al., The structure and synthesis of the liver L casei factor Science, 1946 103(2683): p 667-9 Mitsuda, H., et al., Biochemical Studies on Pteridines in Plants I Biogenesis of Folic Acid in Green Leaves: Confirmation of Enzymatic Synthesis of Folate Compounds by the Enzyme System from the Spinach J Vitaminol (Kyoto), 1965 11: p 122-38 in Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline1998: Washington (DC) Berry, R.J., et al., Fortification of flour with folic acid Food Nutr Bull, 2010 31(1 Suppl): p S22-35 Maree, K.A., J van der Westhuyzen, and J Metz, Interrelationship between serum concentrations of methionine, vitamin B12 and folate Int J Vitam Nutr Res, 1990 60(2): p 136-41 Herbert, V., A.R Larrabee, and J.M Buchanan, Studies on the identification of a folate compound of human serum J Clin Invest, 1962 41: p 1134-8 Wagner, C., Biochemical role of folate in cellular metabolism (Reprinted from Folate and Health Disease, pgs 23-42, 1995) Clinical Research and Regulatory Affairs, 2001 18(3): p 161-180 Green, J.M., R.E Mackenzie, and R.G Matthews, Substrate Flux through Methylenetetrahydrofolate Dehydrogenase - Predicted Effects of the Concentration of Methylenetetrahydrofolate on Its Partitioning into Pathways Leading to Nucleotide Biosynthesis or Methionine Regeneration Biochemistry, 1988 27(21): p 8014-8022 Finkelstein, J.D., Methionine Metabolism in Mammals Journal of Nutritional Biochemistry, 1990 1(5): p 228-237 Zhao, R., L.H Matherly, and I.D Goldman, Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues Expert Reviews in Molecular Medicine, 2009 11 Qiu, A., et al., Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction American Journal of Physiology-Cell Physiology, 2007 293(5): p C1669-C1678 Qiu, A.D., et al., Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption Cell, 2006 127(5): p 917-928 Umapathy, N.S., et al., Cloning and functional characterization of the proton-coupled electrogenic folate transporter and analysis of its expression in retinal cell types Investigative Ophthalmology & Visual Science, 2007 48(11): p 5299-5305 Desmoulin, S.K., et al., Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors 110 REFERENCES 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Based on Selective Uptake by the Proton-Coupled Folate Transporter Molecular Pharmacology, 2011 80(6): p 1096-1107 Zhao, R.B., et al., A prominent Low-pH methotrexate transport activity in human solid tumors: Contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier Clinical Cancer Research, 2004 10(2): p 718-727 Sirotnak, F.M., Obligate Genetic Expression in Tumor-Cells of a Fetal Membrane Property Mediating Folate Transport - Biological Significance and Implications for Improved Therapy of Human Cancer Cancer Research, 1985 45(9): p 3992-4000 Whetstine, J.R., R.M Flatley, and L.H Matherly, The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter Biochemical Journal, 2002 367: p 629-640 Wong, S.C., et al., Isolation of Human Cdnas That Restore Methotrexate Sensitivity and Reduced Folate Carrier Activity in Methotrexate Transport-Defective Chinese-Hamster Ovary Cells Journal of Biological Chemistry, 1995 270(29): p 17468-17475 Wong, S.C., et al., Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier Biochim Biophys Acta, 1998 1375(1-2): p 6-12 Henderson, G.B and E.M Zevely, STRUCTURAL REQUIREMENTS FOR ANION SUBSTRATES OF THE METHOTREXATE TRANSPORT-SYSTEM IN L1210-CELLS Archives of Biochemistry and Biophysics, 1983 221(2): p 438-446 Antony, A.C., THE BIOLOGICAL CHEMISTRY OF FOLATE RECEPTORS Blood, 1992 79(11): p 2807-2820 Mcpartlin, J., et al., Accelerated Folate Breakdown in Pregnancy Lancet, 1993 341(8838): p 148-149 Kibar, Z., V Capra, and P Gros, Toward understanding the genetic basis of neural tube defects Clinical Genetics, 2007 71(4): p 295-310 Rossi, A., et al., Imaging in spine and spinal cord malformations European Journal of Radiology, 2004 50(2): p 177-200 Wald, N., Prevention of Neural-Tube Defects - Results of the MedicalResearch-Council Vitamin Study Lancet, 1991 338(8760): p 131-137 Piedrahita, J.A., et al., Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development Nature Genetics, 1999 23(2): p 228-232 Barber, R.C., et al., Lack of association between mutations in the folate receptor-alpha gene and spina bifida American Journal of Medical Genetics, 1998 76(4): p 310-317 Heil, S.G., et al., Molecular genetic analysis of human folate receptors in neural tube defects European Journal of Human Genetics, 1999 7(3): p 393-396 De Marco, P., et al., Reduced folate carrier polymorphism (80A -> G) and neural tube defects European Journal of Human Genetics, 2003 11(3): p 245-252 vanderPut, N.M.J., T.K.A.B Eskes, and H.J Blom, Is the common 677C->T mutation in the methylenetetrahydrofolate reductase gene a 111 REFERENCES 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 risk factor for neural tube defects? A meta-analysis Qjm-Monthly Journal of the Association of Physicians, 1997 90(2): p 111-115 Botto, L.D and J Mulinare, Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida American Journal of Epidemiology, 1999 150(3): p 323-324 van der Put, N.M.J., et al., A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? American Journal of Human Genetics, 1998 62(5): p 1044-1051 Yang, M., et al., Association between the methionine synthase A2756G polymorphism and neural tube defect risk: A meta-analysis Gene, 2013 520(1): p 7-13 Ma, J., et al., A polymorphism of the methionine synthase gene: Association with plasma folate, vitamin B-12, homocyst(e)ine, and colorectal cancer risk Cancer Epidemiology Biomarkers & Prevention, 1999 8(9): p 825-829 Wilson, A., et al., Molecular basis for methionine synthase reductase deficiency in patients belonging to the cbIE complementation group of disorders in folate/cobalamin metabolism Human Molecular Genetics, 1999 8(11): p 2009-2016 Harker, L.A., et al., Homocystinemia - Vascular Injury and Arterial Thrombosis New England Journal of Medicine, 1974 291(11): p 537543 Boushey, C.J., et al., A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular-Disease - Probable Benefits of Increasing Folic-Acid Intakes Jama-Journal of the American Medical Association, 1995 274(13): p 1049-1057 Brattstrom, L., Vitamins as homocysteine-lowering agents Journal of Nutrition, 1996 126(4): p S1276-S1280 Frosst, P., et al., A Candidate Genetic Risk Factor for VascularDisease - a Common Mutation in Methylenetetrahydrofolate Reductase Nature Genetics, 1995 10(1): p 111-113 Willems, F.F., et al., Thermolabile methylenetetrahydrofolate reductase in coronary artery disease Journal of the American College of Cardiology, 1998 31(2): p 145a-145a Bandera, E.V., et al., Diet and alcohol consumption and lung cancer risk in the New York State cohort (United States) Cancer Causes & Control, 1997 8(6): p 828-840 Lashner, B.A., et al., Effect of Folate Supplementation on the Incidence of Dysplasia and Cancer in Chronic Ulcerative-Colitis - a CaseControl Study Gastroenterology, 1989 97(2): p 255-259 Civitelli, S., et al., Folate status in patients with sporadic and hereditary colorectal cancer Gastroenterology, 1997 112(4): p A549-A549 Glynn, S.A., et al., Colorectal cancer and folate status: A nested casecontrol study among male smokers Cancer Epidemiology Biomarkers & Prevention, 1996 5(7): p 487-494 Brockton, N.T., Systemic folate status and risk of colorectal cancer Cancer Causes & Control, 2008 19(9): p 1005-1007 112 REFERENCES 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 Cravo, M., et al., DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation Eur J Cancer Prev, 1994 3(6): p 473-9 Blount, B.C., et al., Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage Proceedings of the National Academy of Sciences of the United States of America, 1997 94(7): p 3290-3295 Jacob, R.A., et al., Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women J Nutr, 1998 128(7): p 1204-12 Kim, Y.I., et al., Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene American Journal of Clinical Nutrition, 1997 65(1): p 46-52 Farber, S and L.K Diamond, Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid N Engl J Med, 1948 238(23): p 787-93 Walling, J., From methotrexate to pemetrexed and beyond A review of the pharmacodynamic and clinical properties of antifolates Invest New Drugs, 2006 24(1): p 37-77 Appleman, J.R., et al., Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase Journal of Biological Chemistry, 1988 263(21): p 1030413 White, J.C., Reversal of methotrexate binding to dihydrofolate reductase by dihydrofolate Studies with pure enzyme and computer modeling using network thermodynamics Journal of Biological Chemistry, 1979 254(21): p 10889-95 Baggott, J.E., W.H Vaughn, and B.B Hudson, Inhibition of 5aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4carboxamide riboside and ribotide Biochem J, 1986 236(1): p 193200 Goodsell, D.S., The molecular perspective: methotrexate Oncologist, 1999 4(4): p 340-1 Assaraf, Y.G., Molecular basis of antifolate resistance Cancer and Metastasis Reviews, 2007 26(1): p 153-181 Sirotnak, F.M., et al., New Folate Analogs of the 10-DeazaAminopterin Series - Basis for Structural Design and Biochemical and Pharmacologic Properties Cancer Chemotherapy and Pharmacology, 1984 12(1): p 18-25 Sirotnak, F.M., et al., A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice Cancer Chemotherapy and Pharmacology, 1998 42(4): p 313318 Krug, L.M., et al., 10-propargyl-10-deazaaminopterin: An antifolate with activity in patients with previously treated non-small cell lung cancer Clinical Cancer Research, 2003 9(6): p 2072-2078 O'Connor, O.A., et al., Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal 113 REFERENCES 62 63 64 65 66 67 68 69 70 71 72 73 74 75 PROPEL Study Journal of Clinical Oncology, 2011 29(9): p 11821189 Bertino, J.R., et al., 2,4-diamino-5-methyl-6-[(3,4,5trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo Biochem Pharmacol, 1979 28(12): p 1983-7 Liani, E., et al., Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines International Journal of Cancer, 2003 103(5): p 587-599 Takimoto, C.H., New Antifolates: Pharmacology and Clinical Applications Oncologist, 1996 1(1 & 2): p 68-81 Beardsley, G.P., et al., A new folate antimetabolite, 5,10-dideaza5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis Journal of Biological Chemistry, 1989 264(1): p 328-33 Pizzorno, G., et al., 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines Journal of Biological Chemistry, 1993 268(2): p 1017-23 Pizzorno, G., et al., Multifactorial resistance to 5,10dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM Cancer Res, 1995 55(3): p 56673 Ray, M.S., et al., Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis J Natl Cancer Inst, 1993 85(14): p 1154-9 Boritzki, T.J., et al., AG2034: a novel inhibitor of glycinamide ribonucleotide formyltransferase Invest New Drugs, 1996 14(3): p 295-303 Jansen, G., et al., Membrane Transport Properties and Biological Activity of Stereo-isomers of Glycinamide Ribonucleotide Formyltransferase (GARFT) Inhibitors AG2032 and AG2034 Pteridines, 2009 20: p 109-114 Bissett, D., et al., Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034 British Journal of Cancer, 2001 84(3): p 308-312 Jackman, A.L., et al., Ici-D1694, a Quinazoline Antifolate Thymidylate Synthase Inhibitor That Is a Potent Inhibitor of L1210 Tumor-Cell Growth-Invitro and Invivo - a New Agent for Clinical-Study Cancer Research, 1991 51(20): p 5579-5586 Cunningham, D., et al., Efficacy, tolerability and management of raltitrexed (Tomudex (TM)) monotherapy in patients with advanced colorectal cancer: a review of phase II/III trials European Journal of Cancer, 2002 38(4): p 478-486 van Meerbeeck, J.P., et al., Malignant pleural mesothelioma: The standard of care and challenges for future management Critical Reviews in Oncology Hematology, 2011 78(2): p 92-111 Taylor, E.C., et al., A Dideazatetrahydrofolate Analog Lacking a Chiral Center at C-6, N-[4-[2-(2-Amino-3,4-Dihydro-4-Oxo-7hPyrrolo[2,3-D]Pyrimidin-5-Yl)Ethyl]Benzoyl]-L-Glutamic Acid, Is an 114 REFERENCES 76 77 78 79 80 81 82 83 84 85 86 87 88 89 Inhibitor of Thymidylate Synthase Journal of Medicinal Chemistry, 1992 35(23): p 4450-4454 Habeck, L.L., et al., Substrate-Specificity of Mammalian Folylpolyglutamate Synthetase for 5,10-Dideazatetrahydrofolate Analogs Molecular Pharmacology, 1995 48(2): p 326-333 Shih, C., et al., LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes Cancer Research, 1997 57(6): p 1116-1123 Jarmula, A., Antifolate Inhibitors of Thymidylate Synthase as Anticancer Drugs Mini-Reviews in Medicinal Chemistry, 2010 10(13): p 1211-1222 Webber, S., et al., AG337, a novel lipophilic thymidylate synthase inhibitor: In vitro and in vivo preclinical studies Cancer Chemotherapy and Pharmacology, 1996 37(6): p 509-517 Gish, R.G., et al., Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin (vol 25, pg 3069, 2007) Journal of Clinical Oncology, 2007 25(28): p 4512-4512 Gonen, N and Y.G Assaraf, Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance Drug Resistance Updates, 2012 15(4): p 183-210 Antony, A.C., et al., ISOLATION, CHARACTERIZATION, AND COMPARISON OF THE SOLUBILIZED PARTICULATE AND SOLUBLE FOLATE BINDING-PROTEINS FROM HUMAN-MILK Journal of Biological Chemistry, 1982 257(17): p 81-89 Antony, A.C., et al., ISOLATION AND CHARACTERIZATION OF A FOLATE RECEPTOR FROM HUMAN-PLACENTA Journal of Biological Chemistry, 1981 256(18): p 9684-9692 Elnakat, H and M Ratnam, Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy Advanced Drug Delivery Reviews, 2004 56(8): p 1067-1084 Reddy, J.A., et al., Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells Blood, 1999 93(11): p 3940-3948 Shen, F., et al., FOLATE RECEPTOR-TYPE-GAMMA IS PRIMARILY A SECRETORY PROTEIN DUE TO LACK OF AN EFFICIENT SIGNAL FOR GLYCOSYLPHOSPHATIDYLINOSITOL MODIFICATION - PROTEIN CHARACTERIZATION AND CELLTYPE SPECIFICITY Biochemistry, 1995 34(16): p 5660-5665 Zhao, R., et al., A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis Journal of Biological Chemistry, 2009 284(7): p 4267-4274 Rothberg, K.G., et al., THE GLYCOPHOSPHOLIPID-LINKED FOLATE RECEPTOR INTERNALIZES FOLATE WITHOUT ENTERING THE CLATHRIN-COATED PIT ENDOCYTIC PATHWAY Journal of Cell Biology, 1990 110(3): p 637-649 Rothberg, K.G., et al., CHOLESTEROL CONTROLS THE CLUSTERING OF THE GLYCOPHOSPHOLIPID-ANCHORED MEMBRANE-RECEPTOR FOR 5-METHYLTETRAHYDROFOLATE Journal of Cell Biology, 1990 111(6): p 2931-2938 115 REFERENCES 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 Stevens, V.L and J.H Tang, Fumonisin B-1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositolanchored folate receptor Journal of Biological Chemistry, 1997 272(29): p 18020-18025 Wu, M., et al., Clustering of GPI-anchored folate receptor independent of both cross-linking and association with caveolin Journal of Membrane Biology, 1997 159(2): p 137-147 Goresky, C.A., H Watanabe, and D.G Johns, The Renal Excretion of Folic Acid J Clin Invest, 1963 42: p 1841-9 Selhub, J., et al., Renal folate absorption and the kidney folate binding protein I Urinary clearance studies Am J Physiol, 1987 252(4 Pt 2): p F750-6 Selhub, J., S Nakamura, and F.A Carone, Renal folate absorption and the kidney folate binding protein II Microinfusion studies Am J Physiol, 1987 252(4 Pt 2): p F757-60 Birn, H., S Nielsen, and E.I Christensen, Internalization and apicalto-basolateral transport of folate in rat kidney proximal tubule Am J Physiol, 1997 272(1 Pt 2): p F70-8 Wu, D and W.M Pardridge, Blood-brain barrier transport of reduced folic acid Pharm Res, 1999 16(3): p 415-9 Segal, M.B., Transport of nutrients across the choroid plexus Microsc Res Tech, 2001 52(1): p 38-48 Geller, J., et al., Hereditary folate malabsorption: family report and review of the literature Medicine (Baltimore), 2002 81(1): p 51-68 Ramaekers, V.T., et al., Autoantibodies to folate receptors in the cerebral folate deficiency syndrome N Engl J Med, 2005 352(19): p 1985-91 Sweiry, J.H and D.L Yudilevich, Transport of Folates at Maternal and Fetal Sides of the Placenta - Lack of Inhibition by Methotrexate Biochim Biophys Acta, 1985 821(3): p 497-501 Prasad, P.D., et al., Functional Coupling between a Bafilomycin-a(1)Sensitive Proton Pump and a Probenecid-Sensitive Folate Transporter in Human Placental Choriocarcinoma Cells Biochimica Et Biophysica Acta-Molecular Cell Research, 1994 1222(2): p 309-314 Kelemen, L.E., The role of folate receptor alpha in cancer development, progression and treatment: Cause, consequence or innocent bystander? International Journal of Cancer, 2006 119(2): p 243-250 Parker, N., et al., Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Analytical Biochemistry, 2005 338(2): p 284-293 Toffoli, G., et al., Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer International Journal of Cancer, 1998 79(2): p 121-126 Hartmann, L.C., et al., Folate receptor overexpression is associated with poor outcome in breast cancer International Journal of Cancer, 2007 121(5): p 938-942 116 REFERENCES 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 Ross, J.F., et al., Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia Cancer, 1999 85(2): p 348-357 Pan, X.Q., et al., Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid Blood, 2002 100(2): p 594-602 Kane, M.A., et al., INFLUENCE ON IMMUNOREACTIVE FOLATEBINDING PROTEINS OF EXTRACELLULAR FOLATE CONCENTRATION IN CULTURED HUMAN-CELLS Journal of Clinical Investigation, 1988 81(5): p 1398-1406 Matsue, H., et al., FOLATE RECEPTOR ALLOWS CELLS TO GROW IN LOW CONCENTRATIONS OF 5METHYLTETRAHYDROFOLATE Proceedings of the National Academy of Sciences of the United States of America, 1992 89(13): p 6006-6009 Bagnoli, M., et al., Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression Oncogene, 2000 19(41): p 4754-4763 Paulos, C.M., et al., Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis Advanced Drug Delivery Reviews, 2004 56(8): p 1205-1217 Kinne, R.W., et al., Macrophages in rheumatoid arthritis Arthritis Research, 2000 2(3): p 189-202 Nakashima-Matsushita, N., et al., Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis Arthritis and Rheumatism, 1999 42(8): p 1609-1616 Verreck, F.A.W., et al., Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation Journal of Leukocyte Biology, 2006 79(2): p 285-293 Puig-Kroger, A., et al., Folate Receptor beta Is Expressed by TumorAssociated Macrophages and Constitutes a Marker for M2 Antiinflammatory/Regulatory Macrophages Cancer Research, 2009 69(24): p 9395-9403 Ebel, W., et al., Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha Cancer Immun, 2007 7: p Konner, J.A., et al., Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor alpha, in Epithelial Ovarian Cancer: a Phase I Study Clinical Cancer Research, 2010 16(21): p 5288-5295 Armstrong, D.K., et al., Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer Gynecologic Oncology, 2013 129(3): p 452-458 Gibbs, D.D., et al., BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors Cancer Research, 2005 65(24): p 11721-11728 Deng, Y.J., et al., Synthesis and Biological Activity of a Novel Series of 6-Substituted Thieno 2,3-d pyrimidine Antifolate Inhibitors of Purine 117 REFERENCES 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 Biosynthesis with Selectivity for High Affinity Folate Receptors over the Reduced Folate Carrier and Proton-Coupled Folate Transporter for Cellular Entry Journal of Medicinal Chemistry, 2009 52(9): p 2940-2951 Leamon, C.P and J.A Reddy, Folate-targeted chemotherapy Adv Drug Deliv Rev, 2004 56(8): p 1127-41 Wang, S., et al., Design and synthesis of [In-111]DTPA-folate for use as a tumor-targeted radiopharmaceutical Bioconjug Chem, 1997 8(5): p 673-679 Low, P.S and S.A Kularatne, Folate-targeted therapeutic and imaging agents for cancer Curr Opin Chem Biol, 2009 13(3): p 25662 Reddy, J.A., et al., Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate Cancer Res, 2007 67(9): p 4434-42 Leamon, C.P., et al., Synthesis and biological evaluation of EC20: A new folate-derived, Tc-99m-based radiopharmaceutical Bioconjug Chem, 2002 13(6): p 1200-1210 Fisher, R.E., et al., Exploratory study of Tc-99m-EC20 imaging for identifying patients with folate receptor-positive solid tumors Journal of Nuclear Medicine, 2008 49(6): p 899-906 van Dam, G.M., et al., Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first inhuman results Nature Medicine, 2011 17(10): p 1315-U202 Lee, R.J and P.S Low, Folate-Mediated Tumor-Cell Targeting of Liposome-Entrapped Doxorubicin in-Vitro Biochimica Et Biophysica Acta-Biomembranes, 1995 1233(2): p 134-144 Gabizon, A., et al., Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models Cancer Chemotherapy and Pharmacology, 2010 66(1): p 43-52 Monaco, H.L., Crystal structure of chicken riboflavin-binding protein Embo Journal, 1997 16(7): p 1475-1483 Luhrs, C.A., THE ROLE OF GLYCOSYLATION IN THE BIOSYNTHESIS AND ACQUISITION OF LIGAND-BINDING ACTIVITY OF THE FOLATE-BINDING PROTEIN IN CULTURED KB CELLS Blood, 1991 77(6): p 1171-1180 Chang, V.T., et al., Glycoprotein structural genomics: Solving the glycosylation problem Structure, 2007 15(3): p 267-273 Otwinowski, Z and W Minor, Processing of X-ray diffraction data collected in oscillation mode Macromolecular Crystallography, Pt A, 1997 276: p 307-326 Kabsch, W., Xds Acta Crystallographica Section D-Biological Crystallography, 2010 66: p 125-132 Bailey, S., The Ccp4 Suite - Programs for Protein Crystallography Acta Crystallographica Section D-Biological Crystallography, 1994 50: p 760-763 Liu, Q., et al., Structures from Anomalous Diffraction of Native Biological Macromolecules Science, 2012 336(6084): p 1033-1037 Sheldrick, G.M., Experimental phasing with SHELXC/D/E: combining chain tracing with density modification Acta Crystallographica Section D-Biological Crystallography, 2010 66: p 479-485 118 REFERENCES 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 Cowtan, K., dm: An automated procedure for phase improvement by density modification Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography, 1994 31: p 34-38 Emsley, P and K Cowtan, Coot: model-building tools for molecular graphics Acta Crystallogr D Biol Crystallogr, 2004 60(Pt 12 Pt 1): p 2126-32 Terwilliger, T.C., et al., Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard Acta Crystallogr D Biol Crystallogr, 2009 65(Pt 6): p 582-601 Murshudov, G.N., A.A Vagin, and E.J Dodson, Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr D Biol Crystallogr, 1997 53(Pt 3): p 240-55 Baneyx, F., Recombinant protein expression in Escherichia coli Current Opinion in Biotechnology, 1999 10(5): p 411-421 Jaroszewski, L., et al., Genome Pool Strategy for Structural Coverage of Protein Families Structure, 2008 16(11): p 1659-1667 Pioszak, A.A and H.E Xu, Molecular recognition of parathyroid hormone by its G protein-coupled receptor Proceedings of the National Academy of Sciences of the United States of America, 2008 105(13): p 5034-5039 Roberts, S.J., et al., Role of individual N-linked glycosylation sites in the function and intracellular transport of the human alpha folate receptor Archives of Biochemistry and Biophysics, 1998 351(2): p 227-235 Maley, F., et al., Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases Anal Biochem, 1989 180(2): p 195-204 Petrescu, A.J., et al., Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding Glycobiology, 2004 14(2): p 103-114 Davis, S.J., et al., Ligand-Binding by the Immunoglobulin Superfamily Recognition Molecule Cd2 Is Glycosylation-Independent Journal of Biological Chemistry, 1995 270(1): p 369-375 Elbein, A.D., et al., KIFUNENSINE, A POTENT INHIBITOR OF THE GLYCOPROTEIN PROCESSING MANNOSIDASE-I Journal of Biological Chemistry, 1990 265(26): p 15599-15605 Wibowo, A.S., et al., Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition Proc Natl Acad Sci U S A, 2013 110(38): p 15180-8 Yang, J., et al., Characterization of the pH of folate receptorcontaining endosomes and the rate of hydrolysis of internalized acidlabile folate-drug conjugates J Pharmacol Exp Ther, 2007 321(2): p 462-8 Kwon, H.J., et al., Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol Cell, 2009 137(7): p 1213-1224 Anderson, A.C., The process of structure-based drug design Chem Biol, 2003 10(9): p 787-97 Matthews, D.A., et al., Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate Science, 1977 197(4302): p 452-5 119 REFERENCES 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 Hawser, S., S Lociuro, and K Islam, Dihydrofolate reductase inhibitors as antibacterial agents Biochem Pharmacol, 2006 71(7): p 941-8 Lamb, K.M., et al., Elucidating Features That Drive the Design of Selective Antifolates Using Crystal Structures of Human Dihydrofolate Reductase Biochemistry, 2013 52(41): p 7318-7326 Bhabha, G., et al., Divergent evolution of protein conformational dynamics in dihydrofolate reductase Nat Struct Mol Biol, 2013 20(11): p 1243-9 Oefner, C., A D'Arcy, and F.K Winkler, Crystal structure of human dihydrofolate reductase complexed with folate Eur J Biochem, 1988 174(2): p 377-85 Kumar, M., R Vijayakrishnan, and G Subba Rao, In silico structurebased design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery Mol Divers, 2010 14(3): p 595-604 Gangjee, A., et al., Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles J Med Chem, 2013 56(11): p 4422-41 Dasgupta, T., et al., Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria ACS Chem Biol, 2009 4(1): p 29-40 Stock, C.C., et al., Azaserine, a new tumour-inhibitory substance; studies with Crocker mouse sarcoma 180 Nature, 1954 173(4393): p 71-2 Taylor, E.C., et al., Synthesis of the antileukemic agents 5,10dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin J Med Chem, 1985 28(7): p 914-21 Pizzorno, G., et al., (6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells Cancer Res, 1991 51(9): p 2291-5 Sessa, C., et al., Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescue Clinical Cancer Research, 1996 2(7): p 1123-7 Almassy, R.J., et al., Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase Proc Natl Acad Sci U S A, 1992 89(13): p 6114-8 Roberts, J.D., et al., Phase I study of AG2034, a targeted GARFT inhibitor, administered once every weeks Cancer Chemother Pharmacol, 2000 45(5): p 423-7 Webber, S., et al., AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies Cancer Chemother Pharmacol, 1996 37(6): p 509-17 Hardy, L.W., et al., Atomic structure of thymidylate synthase: target for rational drug design Science, 1987 235(4787): p 448-55 Matthews, D.A., et al., Crystal structure of Escherichia coli thymidylate synthase containing bound 5-fluoro-2'-deoxyuridylate and 10-propargyl-5,8-dideazafolate J Mol Biol, 1990 214(4): p 923-36 120 REFERENCES 171 172 173 174 175 176 177 Phan, J., et al., Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug Biochemistry, 2001 40(7): p 1897-902 Sotelo-Mundo, R.R., et al., Crystal structures of rat thymidylate synthase inhibited by Tomudex, a potent anticancer drug Biochemistry, 1999 38(3): p 1087-94 Webber, S.E., et al., Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones J Med Chem, 1993 36(6): p 733-46 Bavetsias, V., et al., Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,) J Med Chem, 2000 43(10): p 1910-26 Gangjee, A., et al., Synthesis of classical, three-carbon-bridged 5substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3d]pyrimidine analogues as antifolates J Med Chem, 2004 47(27): p 6893-901 Deng, Y., et al., Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activity J Med Chem, 2008 51(16): p 505263 Deng, Y., et al., Synthesis and biological activity of a novel series of 6substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry J Med Chem, 2009 52(9): p 2940-51 121 PUBLICATIONS PUBLICATIONS Chen, C.*, Ke, J.*, Zhou, X.E., Yi, W., Brunzelle, J.S., Li, J., Yong, E.L., Xu, H.E., and Melcher, K (2013) Structural basis for molecular recognition of folic acid by folate receptors Nature 500, 486-489 Ke, J., Chen, R.Z., Ban, T., Zhou, X.E., Gu, X., Tan, M.H., Chen, C., Kang, Y., Brunzelle, J.S., Zhu, J.K., et al (2013) Structural basis for RNA recognition by a dimeric PPR-protein complex Nature structural & molecular biology 20, 1377-1382 Ke, J., Harikumar, K.G., Erice, C., Chen, C., Gu, X., Wang, L., Parker, N., Cheng, Z., Xu, W., Williams, B.O., et al (2013) Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex Genes & development 27, 2305-2319 Tiong, C.T., Chen, C., Zhang, S.J., Li, J., Soshilov, A., Denison, M.S., Lee, L.S., Tam, V.H., Wong, S.P., Xu, H.E., et al (2012) A novel prenylflavone restricts breast cancer cell growth through AhRmediated destabilization of ERalpha protein Carcinogenesis 33, 10891097 Notes and author contributions: *These authors contribute equally to this work The scope of this thesis is based on publication 122 ... form of folate in circulation is 5-methyl tetrahydrofolate (5-methyl THF) [7] a) b) Figure Chemical structure of folic acid and folate derivatives a) Constitution of folic acid b) Tetrahydrofolate... crystal structure of FRα -folic acid complex which provided the molecular basis for the high affinity binding Folate receptor is a globular protein which consists of six helices, two pairs of β-sheets... complementary to folic acid The basic pteroate head of folic acid is buried within the positively charged interior of the pocket, whilst the acidic tail of folic acid is stabilized by the negatively